PREDIKSI ADMET DAN MOLECULAR DOCKING METABOLIT SEKUNDER CENTELLA ASIATICA SEBAGAI CALON ANTIKANKER PAYUDARA
DOI:
https://doi.org/10.36423/pharmacoscript.v7i1.1413Keywords:
Centella asiatica, kanker payudara, in silicoAbstract
Kanker payudara merupakan penyakit yang ditandai oleh pembelahan sel payudara yang tidak terkendali, karena mutasi atau perubahan abnormal. Doxorubicin adalah agen kemoterapi standart untuk kanker payudara, namun memiliki efek samping dan dapat menyebabkan resistensi obat. Pemanfaatan bahan alam Indonesia dapat digunakan sebagai sarana pengobatan alternatif/komplementer, dengan keunggulan efek samping relatif kecil dibanding bahan kimia sintetis. Centella asiatica adalah salah satu tanaman yang dapat dimanfaatkan untuk pengobatan tradisional antikanker. Dalam pengembangan dan penemuan obat baru membutuhkan biaya yang besar, waktu yang lama serta tenaga yang banyak karena perlu dilakukan uji coba dan sintesis pada sebagian besar prosesnya tanpa adanya desain atau alasan yang jelas. Penelitian ini bertujuan untuk mengetahui aktivitas sitotoksik metabolit sekunder Centella asiatica, secara in silico. Pengujian yang dilakukan adalah prediksi sifat fisikokimia druglikeness, ADME-Tox, serta molecular docking metabolit sekunder dan obat pembanding Doxorubicin terhadap target reseptor SIRT1 (kode PBD: 4I5I.pdb) mengguankan program Autodock Vina. Dengan hasil energi ikatan yang lebih baik daripada obat pembanding Doxorubicin (-9,46kkal/mol), yaitu 3-O-cis-Caffeoylquercetin (-10.34kkal/mol), Quercetin (-10.28kkal/mol), dan 3-O-cis-Coumaroyl-kaempferol (-10.19kkal/mol). Maka metabolit sekunder Centella asiatica terbaik secara in sillico, yang dapat digunakan sebagai calon antikanker payudara adalah 3-O-cis-Caffeoylquercetin.References
Global Cancer Observatory (2022, 24 Oktober). New Global Cancer Data. Diakses pada 20 Desember 2022, dari https://gco.iarc.fr/
National Health Service (2019, 13 Oktober). Overview Cancer. Diakses pada 17 November 2022 pada https://www.-nhs.uk/conditions/cancer/#:~:text=-Cancer%20treatment,of%20high%2Denergy%20X%2Drays.
Bandyopadhyay, A., Wang, L., Agyin, J., Tang, Y., Lin, S., Yeh, I.-T., De, K., & Sun, L.-Z. (2010), Doxorubicin in Combination with a Small TGFb Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models. PLoS ONE, 5(4), 13. https://doi.org/10.1371/journal.pone.0010365
Sieberi, B. M., Omwenga, G. I., Wambua, R. K., Samoei, J. C., & Ngugi, M. P. (2020). Screening of the Dichloromethane: Methanolic Extract of Centella asiatica for Antibacterial Activities against Salmonella typhi, Escherichia coli, Shigella sonnei, Bacillus subtilis, and Staphylococcus aureus. The Scientific World Journal, 2020.
Pittella F, Dutra RC, Junior DD, Lopes MT, Barbosa NR: Antioxidant and cytotoxic activities of Centella asiatica (L) Urb. Int J Mol Sci 2009, 10(9):3713–3721.
Jasmansyah, J., Fitriyani, P., Sujono, H., & Aisyah, L. S. (2020). Antimicrobial Activity of Essential Oil from Centella asiatica (L.) Urb Plant. Jurnal Kartika Kimia, 3(1), 43-47.a
H. Zhang, L.-Q. Zhang, C.-C. Yang, J. Li, X.-Y. Tian, D.-N. Li, J. Cui, J.-P. Cai, The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT/Cyclin D signaling, PLoS One 16 (2021), e0245876.
Siswandono (2016) ‘Kimia Medisinal 1 Edisi 2 - Google Books’. Available at: https://www.google.co.id/books/edition/Kimia_Medisinal_1_Edisi_2/UKbJD1
D. Kesuma, B. T. Purwanto, and M. Rudyanto, “Synthesis and anticancer evalution of N-benzoyl-N-phenyltiourea derivatives against human breast cancer cell (T47D),” J. chinese Pharm. Sci., pp. 123–129, 2020.
Lu Ren, Qin-Xue Cao, Feng-Rong Zhai, Shao-Qin Yang & Hong-Xia Zhang (2016) Asiatic acid exerts anticancer potential in human ovarian cancer cells via suppression of PI3K/Akt/mTOR signalling, Pharmaceutical Biology, 54:11, 2377-2382, DOI: 10.3109/13880209.2016.1156709.
Yasmin, R., Mafiroh W.U., Kinasih, A., Ramadhani, A.N., Putri, R., Semiarti, E. (2022). Potential of Anti-Cancer and Antimicrobial in Orchid Based on Prediction of Activity Spectra for Substances (Pass) Online. Journal of Agromedicine and Medical Sciences, 8(1), 25-33. https://doi.org/10.19184/-ams.v8i1.2684 8
Hanif, Atika Umi, Prima Agusti Lukis, Arif Fadlan (2021). Pengaruh Minimisasi Energi MMFF94 dengan MarvinSketch dan Open Babel PyRx pada Penambatan Molekular Turunan Oksindola Tersubstitusi. Alchemy: Journal of Chemistry, 8(2) 33-40.
Daina, A., Michielin, O., Zoete, V. 2017. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7: 1-13.
Mohammed Afroz Bakht, M. Shahar Yar, Sami Gaber Abdel -Hamid, Saleh I. Al Qasoumi, Abdul Samad, Molecular properties prediction, synthesis and anti - microbial activity of some newer oxadiazole derivatives, European Journal of Medicinal Chemistry , 45, 12, (2010), 5862 -5869 https://doi.org/10.1016/j.ejmech.2010.07.069
Frengki, Saura, E.R., Rinidar. 2013. Studi interaksi kurkumin-artemisin dan turunannya terhadap reseptor sarcoendoplasma reticulum Ca2+ secara in silico. Jurnal Medika Veterinaria, 7(2): 138-141.
Yeni, Supandi, Fajar Merdekawati (2018). In silico toxicity prediction of 1-phenyl-1-(quinazolin-4-yl) ethanol compounds by using Toxtree, pkCSM and preADMET. Pharmaciana. 10.12928/pharmaciana.v8i2.9508
Baroroh Umim zahra Silmi Muscifa, Wanda Destiarani, Fauziah Giansyah Rohmatulloh, Muhammad Yusuf (2023). Molecular interaction analysis and visualization of protein-ligand docking using Biovia Discovery Studio Visualizer. Indonesian Journal of Computational Biology, 2(1), 22-30.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 farah Fadhilah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication, with the work [SPECIFY PERIOD OF TIME] after publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).